Treatment of diabetic gastroparesis with nitric oxide

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$367,554.00
Award Year:
2007
Program:
SBIR
Phase:
Phase I
Contract:
1R43DK078467-01
Award Id:
85577
Agency Tracking Number:
DK078467
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
AMULET PHARMACEUTICALS, INC., 9430 Key West Avenue, Rockville, MD, 20850
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
148048460
Principal Investigator:
ROBERT RAULLI
(410) 455-5747
RRAULLI@AMULETPHARMA.COM
Business Contact:
ROBERT RAULLI
() -
rraulli@amuletpharma.com
Research Institute:
n/a
Abstract
DESCRIPTION (provided by applicant): This proposal will establish proof of concept for the use of nitric oxide (NO) as an effective treatment for diabetic gastroparesis. The NO will be delivered using Amulet's NORTECH nitric oxide releasing technology. NOR TECH delivers NO in a predictable and controllable manner, and without the possibility of forming carcinogenic nitrosamines. NORTECH is uniquely able to deliver biologically active levels of NO for a sustained period at gastric pH (2.0), making it an ideal agent to deliver NO to the stomach. The NORTECH will be tested in an animal model of diabetic gastroparesis. The proof of concept will constitute studies that include a determination of the optimal dosing time (i.e. a range of time points from 30 min befo re meals to 60 min after meals), the establishment of a dose-response relationship and comparison with metoclopramide (a currently used but problematic treatment), and a study of how NO affects the physiological mechanisms of gastric emptying. Successful c ompletion of the specific aims of the proposal will definitively determine the feasibility of using NORTECH as a treatment for gastroparesis. Up to 25% of the global diabetic population suffers from gastroparesis. The disease can cause extreme discomfort, pain, frequent vomiting and leads to a very low quality of life for those who suffer from its effects. Currently there is no adequate treatment. An effective treatment for gastroparesis can significantly benefit the quality of life for those who suffer fro m the disease.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government